Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$14.36
+3.39%
Mkt Cap $10.76B
Analyst Ratings
Buy
4
Hold
3
Sell
0
Price Target (18 analysts)
$26.00
Range $16.00 – $40.00
Implied Upside
+81.1%
Consensus $26.00 vs current $14.36
NASDAQ·Healthcare·Biotechnology
$14.36
+3.39%
Mkt Cap $10.76B
Buy
4
Hold
3
Sell
0
Price Target (18 analysts)
$26.00
Range $16.00 – $40.00
+81.1%
Consensus $26.00 vs current $14.36